C4 Therapeutics, Inc. Share Price

C4 Therapeutics, Inc. Share Price

NASDAQ: CCCC | Micro Cap
$3.31
-$0.11 (-3.36%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

C4 Therapeutics, Inc. Stock Performance

Open
$3.42
Prev. Close
$3.42
Circuit Range
N/A
Day Range
$3.21 - $3.43
Year Range
$1.70 - $5.17
Volume
1,91,934
Average Traded
$3.31

C4 Therapeutics, Inc. Share Price Today

As of 30 October 2026, C4 Therapeutics, Inc.'s share price is $3.31. The stock opened at $3.42, compared to its previous close of $3.42. During today's trading session, C4 Therapeutics, Inc.'s share price traded between $3.21 and $3.43, with an average price of $3.32. Over the past 52 weeks, the stock has recorded a high of $5.17 and a low of $1.70. In terms of performance, C4 Therapeutics, Inc.'s share price has risen by 16.96% over the last six months and is up 27.06% on a year-on-year basis.

C4 Therapeutics, Inc. Share Price Chart

Line chart of the C4 Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 3.21 to 3.43, ending at 3.31.
$3.21$3.43
L
Show Current Price
H

C4 Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$274.38M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.82
Revenue (TTM)
$35.95B
Return On Equity (TTM)
-41.02%
Profit Margin
-292.04%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
26.52%

C4 Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$11.23$11.02$6.15$6.64
Net Profit-$32.17-$20.49-$25.13-$23.64
Net Profit Margin-286.46%-185.93%-408.62%-356.02%
Income ChangeN/A36.31%-22.65%5.93%

C4 Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$31.10$20.76$35.58$35.95
Net Profit-$128.18-$132.49-$105.32-$104.99
Net Profit Margin-412.15%-638.20%-296.01%-292.04%
Income ChangeN/A-3.36%20.51%0.31%

About C4 Therapeutics, Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

C4 Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.35
$3.31
-0.75%
Sep 2026
$3.69
$3.33
-18.58%
Aug 2026
$3.46
$4.09
+17.19%
Jul 2026
$4.71
$3.49
-24.95%
Jun 2026
$4.34
$4.65
+5.92%
May 2026
$2.77
$4.39
+55.12%
Apr 2026
$2.67
$2.83
+7.60%
Mar 2026
$2.63
$2.63
-2.77%
Feb 2026
$1.89
$2.71
+43.12%
Jan 2026
$1.97
$1.89
-1.05%
Dec 2025
$2.60
$1.91
-29.26%
Nov 2025
$2.60
$2.70
+3.65%

CCCC Share Price FAQs